Sabine B. Schleicher

Tuebingen, BW 72076, Germany

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 28 publications

Preclinical Evaluation of CRISPR-Edited CAR-NK-92 Cells for Off-the-Shelf Treatment of AML and B-ALL.

Preclinical Evaluation of CRISPR-Edited CAR-NK-92 Cells for Off-the-Shelf Treatment of AML and B-ALL.

Journal: International journal of molecular sciences
Published: September 23, 2022

Novel adapter CAR-T cell technology for precisely controllable multiplex cancer targeting.

Novel adapter CAR-T cell technology for precisely controllable multiplex cancer targeting.

Journal: Oncoimmunology
Published: June 10, 2022

TH1 cytokines induce senescence in AML.

TH1 cytokines induce senescence in AML.

Journal: Leukemia research
Published: March 02, 2022

The Effect of Direct and Indirect EZH2 Inhibition in Rhabdomyosarcoma Cell Lines.

The Effect of Direct and Indirect EZH2 Inhibition in Rhabdomyosarcoma Cell Lines.

Journal: Cancers
Published: October 29, 2021

Repurposing Disulfiram for Targeting of Glioblastoma Stem Cells: An In Vitro Study.

Repurposing Disulfiram for Targeting of Glioblastoma Stem Cells: An In Vitro Study.

Journal: Biomolecules
Published: September 24, 2021

In Vitro Evaluation of CD276-CAR NK-92 Functionality, Migration and Invasion Potential in the Presence of Immune Inhibitory Factors of the Tumor Microenvironment.

In Vitro Evaluation of CD276-CAR NK-92 Functionality, Migration and Invasion Potential in the Presence of Immune Inhibitory Factors of the Tumor Microenvironment.

Journal: Cells
Published: March 04, 2021

Arsenic trioxide in pediatric cancer - a case series and review of literature.

Arsenic trioxide in pediatric cancer - a case series and review of literature.

Journal: Pediatric hematology and oncology
Published: February 26, 2021

Adapter chimeric antigen receptor (AdCAR)-engineered NK-92 cells: an off-the-shelf cellular therapeutic for universal tumor targeting.

Adapter chimeric antigen receptor (AdCAR)-engineered NK-92 cells: an off-the-shelf cellular therapeutic for universal tumor targeting.

Journal: Oncoimmunology
Published: January 18, 2021

Adapter Chimeric Antigen Receptor (AdCAR)-Engineered NK-92 Cells for the Multiplex Targeting of Bone Metastases.

Adapter Chimeric Antigen Receptor (AdCAR)-Engineered NK-92 Cells for the Multiplex Targeting of Bone Metastases.

Journal: Cancers
Published: January 10, 2021

Establishment and Characterization of a Sclerosing Spindle Cell Rhabdomyosarcoma Cell Line with a Complex Genomic Profile.

Establishment and Characterization of a Sclerosing Spindle Cell Rhabdomyosarcoma Cell Line with a Complex Genomic Profile.

Journal: Cells
Published: October 14, 2020

In the Absence of a TCR Signal IL-2/IL-12/18-Stimulated γδ T Cells Demonstrate Potent Anti-Tumoral Function Through Direct Killing and Senescence Induction in Cancer Cells.

In the Absence of a TCR Signal IL-2/IL-12/18-Stimulated γδ T Cells Demonstrate Potent Anti-Tumoral Function Through Direct Killing and Senescence Induction in Cancer Cells.

Journal: Cancers
Published: November 25, 2019

GD2-targeted chimeric antigen receptor T cells prevent metastasis formation by elimination of breast cancer stem-like cells.

GD2-targeted chimeric antigen receptor T cells prevent metastasis formation by elimination of breast cancer stem-like cells.

Journal: Oncoimmunology
Published: August 10, 2019
Showing 1-12 of 28

Last Updated: 09/26/2026